References
- Andres SN, Schellenberg MJ, Wallace BD, Tumbale P, Williams RS. Recognition and repair of chemically heterogeneous structures at DNA ends. Environ Mol Mutagen 2015; 56:1-21; PMID:25111769; http://dx.doi.org/10.1002/em.21892
- Aparicio T, Baer R, Gautier J. DNA double-strand break repair pathway choice and cancer. DNA Repair 2014; 19:169-75; PMID:24746645; http://dx.doi.org/10.1016/j.dnarep.2014.03.014
- Symington LS, Gautier J. Double-strand break end resection and repair pathway choice. Annu Rev Genet 2011; 45:247-71; PMID:21910633; http://dx.doi.org/10.1146/annurev-genet-110410-132435
- Liu LF, Rowe TC, Yang L, Tewey KM, Chen GL. Cleavage of DNA by mammalian DNA topoisomerase II. J Biol Chem 1983; 258:15365-70; PMID:6317692
- Hartsuiker E, Neale MJ, Carr AM. Distinct requirements for the Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound topoisomerase I and II from DNA. Mol Cell 2009; 33:117-23; PMID:19150433; http://dx.doi.org/10.1016/j.molcel.2008.11.021
- Neale MJ, Pan J, Keeney S. Endonucleolytic processing of covalent protein-linked DNA double-strand breaks. Nat Cell Biol 2005; 436:1053-7; PMID:16107854; http://dx.doi.org/10.1038/nature03872
- Aparicio T, Baer R, Gottesman M, Gautier J. MRN, CtIP, and BRCA1 mediate repair of topoisomerase II–DNA adducts. J Cell Biol 2016; 212:399-408; PMID:26880199; http://dx.doi.org/10.1083/jcb.201504005
- Malik M, Nitiss JL. DNA repair functions that control sensitivity to topoisomerase-targeting drugs. Eukaryot Cell 2004; 3:82-90; PMID:14871939; http://dx.doi.org/10.1128/EC.3.1.82-90.2004